Actively Recruiting

All Genders
NCT02432092

Pediatric Cardiomyopathy Mutation Analysis

Led by Indiana University · Updated on 2025-06-26

300

Participants Needed

1

Research Sites

874 weeks

Total Duration

On this page

Sponsors

I

Indiana University

Lead Sponsor

A

American Heart Association

Collaborating Sponsor

AI-Summary

What this Trial Is About

The goal of this protocol is to obtain information from individuals with cardiomyopathy and from their families in order to elucidate the molecular genetics of this disorder. This will provide the basis for future genetic counseling as well as contribute to elucidating the biology of normal and abnormal cardiac function.

CONDITIONS

Official Title

Pediatric Cardiomyopathy Mutation Analysis

Who Can Participate

All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Subjects with cardiomyopathy
  • Family members of subjects with cardiomyopathy
Not Eligible

You will not qualify if you...

  • Subjects without cardiomyopathy
  • Family members of subjects without cardiomyopathy

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

IU School of Medicine

Indianapolis, Indiana, United States, 46202

Actively Recruiting

Loading map...

Research Team

L

Lindsey Helvaty, BS, BA

CONTACT

S

Stephanie Ware, MD, PhD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here